首页> 外文期刊>Ophthalmic Surgery and Lasers >Perifoveal laser treatment for subfoveal choroidal neovascularization in age-related macular degeneration.
【24h】

Perifoveal laser treatment for subfoveal choroidal neovascularization in age-related macular degeneration.

机译:眼周脉络膜激光治疗与年龄相关的黄斑变性的小凹下脉络膜新生血管。

获取原文
获取原文并翻译 | 示例
           

摘要

The management of subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration presents a major therapeutic dilemma. No treatment may lead to severe visual loss, and direct laser treatment to the entire subfoveal lesion results in acute loss of visual acuity. Encouraging results have been described with a foveal-sparing laser technique for subfoveal CNV. The authors performed perifoveal confluent laser treatment on a relatively well-defined occult CNV, sparing the foveal avascular zone. One month after treatment, the visual acuity had improved from 20/400 to 20/30. At 24 months, the visual acuity was 20/40 with no recurrence. Confluent perifoveal laser treatment for subfoveal CNV may be useful in preserving central visual acuity in selected patients.
机译:继发于与年龄有关的黄斑变性的继发性小凹下脉络膜新生血管形成(CNV)提出了主要的治疗难题。没有任何治疗方法可能会导致严重的视力丧失,直接激光治疗整个小凹下病变会导致视力急剧下降。使用凹凹激光治疗凹下CNV的结果令人鼓舞。作者在一个相对明确的隐匿性CNV上进行了小凹周围融合激光治疗,保留了小凹无血管区域。治疗一个月后,视力从20/400提高到20/30。在24个月时,视力为20/40,无复发。小凹下CNV的融合小凹激光治疗可能对保持选定患者的中心视力有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号